Date Title Description PDF
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download

Pages

Date Title Description PDF
15 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 5 November 2021 and 12 November 2021 Download
05 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Download
03 Nov 2021 On business and financial situation The Company releases the first nine months 2021 financial results presentation Download
03 Nov 2021 On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Download
21 Oct 2021 Liquidity and counterparty agreements Download

Pages

Date Title Description PDF
07 Nov 2011 Otros sobre Gobierno Corporativo Download
19 Oct 2011 I+D resultados obtenidos; licencias, patentes y marcas Download
26 Sep 2011 Acuerdos estratégicos con terceros Download
23 Sep 2011 Acuerdos estratégicos con terceros Download

Pages